This study aimed to demonstrate the beneficial effects of nutritional supplementation with dietary milk fat globule membrane (MFGM) on physical performance and skeletal muscle function in healthy adults aged 60 and over with semiweekly light exercise. The study was designed as a randomized double-blind controlled trial. Twenty-two Japanese participants (10 men, 12 women) aged 60-73 y were assigned to one of two groups (11 [5 men, 6 women] in each). One group received MFGM tablets (1 g MFGM/d), and the other received placebo tablets daily for 10 wk. Both groups participated in a twice-weekly light exercise program. Physical function tests and surface electromyography (EMG) were conducted at the baseline and after 5 and 10 wk. Chair stand time significantly shortened in both groups after 10 wk compared with that at the baseline. The average time shortened more considerably in the MFGM group than in the placebo group, although the change was not statistically significant. Both knee extension strength and the cross-sectional area of the quadriceps muscles significantly increased from baseline in the MFGM group but not in the placebo group. Surface EMG showed that muscle fiber conduction velocity increased significantly after 10 wk from the baseline only in the MFGM group. The increase from the baseline was significantly greater in the MFGM group than in the placebo group. Daily supplementation with MFGM increased motor unit action potential conduction and improved muscle strength and physical performance in healthy Japanese adults aged 60 y and over paired with semiweekly light exercise.
The global average life expectancy reached 71 y in 2013, while the average healthy life expectancy was 62 y (1) . During this gap period, physical disability and diseases prevent people from performing daily activities and from having good mental health, causing a significant decline in quality of life. Therefore, staying healthy is an important challenge for most individuals over the age of 60 y.
Fall-related injuries and deaths among older adults present an increasingly important healthcare problem worldwide (2) . Physiological impairments, such as impaired muscle strength and balance, coupled with age-related changes in muscles and nerves are likely to contribute to an increased risk of falls in older adults. Regular exercise may be one strategy for preventing falls by improving physical function in older adults (3, 4) . High-intensity exercise is effective for increasing physical function, but it is not practical for older adults due to a decline in physical performance and health problems (5, 6) . Therefore, boosting the beneficial effects of light exercise may be a feasible strategy for older adults to improve physical function more efficiently.
Nutritional supplementation, when combined with light exercise, may facilitate more pronounced physical improvement in this population. Recent studies demonstrated that dietary supplementation with amino acids (7) or tea catechins (8) combined with low-intensity regular exercise improved physical performance, muscle mass, and strength in older adults.
The milk fat globule membrane (MFGM) is the structural membrane covering triglyceride globules that are dispersed as emulsified bodies in milk (9) , and it is prepared from buttermilk by filtration and centrifugation (10) . The MFGM contains unique polar lipids and membrane-specific proteins (9) , and several nutritional benefits of MFGM components, such as anti-cancer and anti-cholesterolemic effects, have been reported (11) . However, the efficacy of MFGM for physical function is not fully understood.
Our recent studies have demonstrated that dietary supplementation with MFGM, when combined with voluntary habitual exercise, improves both muscle mass and strength (12) , and endurance capacity in mice (13) . Our previous study revealed that the beneficial effects of dietary MFGM on skeletal muscles were associated with the stimulation of neuromuscular junction (NMJ) development, which is a critical structure of a motor unit. Since the motor unit is the critical functional unit involved in physical movement, an increase in active motor units may lead to improvement in physical function. In fact, our recent study has demonstrated that MFGM intake along with regular exercise enhanced physical agility by promoting fast-type motor unit maintenance in middle-aged adults (14) .
However, whether dietary MFGM combined with lowintensity, low-frequency exercise can improve motor unit and physical function in the older adult population has yet to be investigated, particularly in light of the major changes in physical and muscle function at age 60 and over that have now been reported. Muscle strength in lower limbs declines markedly after 60 y of age (15) . In a 10-y prospective population-based study, the patterns of loss in grip-strength scores from the ages of 50, 60, and 70 y were consistent, whereas balance and gait performance were significantly impaired from 60 and 70 y old onwards, respectively (16) .
Accordingly, this study aimed to demonstrate the beneficial effects of daily nutritional supplementation with MFGM combined with semiweekly light exercise on physical performance, muscle strength, and motor unit function in adults aged 60 y and over.
MATERIALS AND METHODS
Study participants. Participants were 10 male and 12 female Japanese healthy volunteers aged 60-73 y. Those with coronary heart disease or uncontrolled hypertension, or who participated in any kind of resistance training during the recruitment process were excluded. Participants were instructed not to change their daily exercise intensity or diet during the study period. After the participants were fully informed of the study details, written informed consent was obtained from all participants. The study was performed under the supervision of an occupational health physician, in accordance with the regulations of the Kao Corporation Ethics Committee for Internal Clinical Studies (approved No.317-20110727) and in conformity with the Helsinki Declaration.
Study design and randomization. The study was performed following a double-blind randomized controlled design. A person who was not involved in this study conducted the randomization procedure, and the participants and test staff remained unaware of the assignments throughout the study. The study was conducted from August to December 2011. Randomization was performed after baseline assessment, and the participants were randomly divided into two groups; those who received placebo tablets were classified in the Placebo group, while those who received MFGM tablets were classified in the MFGM group. The participants ingested either MFGM or placebo tablets every day for the 10-wk study period and participated in the exercise training twice per week. Physical function tests were performed at the baseline, the 5-wk point, and the end of the 10-wk intervention. Each participant wore an electric pedometer (FB-732, Tanita Co., Tokyo, Japan) on their hip throughout the test period, and the daily activity was monitored. To track their dairy product intake, they were instructed to record their intake of milk and dairy products on given record sheets.
MFGM consumption. The test tablets contained 167 mg MFGM per tablet and were produced by direct compression. The composition of MFGM was 21.5% protein, 44.0% fat, 26.5% carbohydrate, 33.3% phospholipids (8.03% sphingomyelin), 6.4% ash, and 1.6% moisture. Whole milk powder (Meiji Co., Tokyo, Japan) was used instead of MFGM for preparation of the placebo tablet. The composition of the whole milk powder was 26.3% protein, 25.2% fat, 39.5% carbohydrate, 0.286% phospholipids (0.057% sphingomyelin), 5.7% ash, and 3.3% moisture. The placebo tablets were indistinguishable from the test tablets in shape, taste, and texture.
Each participant consumed six tablets (1 g MFGM or whole milk powder) daily for 10 wk. On the days of exercise training, the participants were instructed to consume the tablets within an hour prior to exercising. On the other days, the participants were instructed to consume the tablets at their preferred time during daily physical activities.
Exercise training. Each participant underwent exercise training twice per week, on nonconsecutive days, for 10 wk, at a designated facility under the supervision of a professional physician. The exercise program consisted of 15-min sessions each of low-intensity walking and cycle training (controlled at 50% of maximum heart rate). The exercise intensity for each participant was determined beforehand based on preliminary measurements.
Physical function test. The following tests were performed before and after 5 and 10 wk of the intervention period. Muscle cross-sectional area (CSA) was measured before and after 10 wk.
Anthropometric measurements. Height was measured before the intervention period. Body weight, body fat ratio, and muscle mass were measured with a bioelectrical impedance body fat analyzer (BC-621, Tanita, Co.).
Knee extension strength. Each leg's isometric knee extension strength was measured by using the Force Measurement System for One Leg (T.K.K.5715, Takei Scientific Instruments Co., Niigata, Japan) equipped with a tensiometer D (T.K.K.5710e, Takei Scientific Instruments Co.) (17) . The participants performed two maximal three-second voluntary contractions at 90˚ knee flexion with 10 s of rest between each measurement. The maximal isometric knee extension strength was calculated by each leg's average muscle peak strength.
Chair stand test. A chair stand test was conducted to evaluate agility and muscular endurance. The participants stood up and sat down on a firm chair five times as quickly as possible, with arms folded in front of their chests (18) . The time required to complete the five cycles was measured.
Muscle cross-sectional area (CSA). Magnetic resonance imaging of each thigh was obtained by using a 1.5 T superconducting system (EXCELART Vantage 1.5T, Toshiba Medical Systems Co., Tokyo, Japan) to obtain the CSA of quadriceps muscles. The thigh image, obtained at 100 mm proximal to the knee joint, was utilized for calculation of the CSA by using a SCION image (19) .
Surface electromyography (EMG). Surface EMG analysis was carried out on all male participants (Placebo group, n55; MFGM group, n55). EMG signals of the intermediate portion of the right vastus medialis were acquired during knee extension strength measurement with a multiple electrode composed of eight parallel platinum wires (diameter, 1.0 mm; length, 10.0 mm; distance between each electrode, 5.0 mm; Unique Medical, Tokyo, Japan). The EMG signal was amplified by a differential bioelectric amplifier (AB-611J, Nihon-Kohden Co., Tokyo, Japan), and the frequency range of amplifier was set from 5 to 1,000 Hz. After the A/D conversion, the root mean square (RMS) amplitude was calculated by using a time epoch of 1 s for the EMG. Muscle fiber conduction velocity (MFCV) was estimated using crosscorrelation, and signals with correlation coefficients of $0.8 were adopted to calculate the MFCV (20) .
Statistical analysis. All data are expressed as means6 SE. A two-way analysis of variance (ANOVA) was performed by using time point as the repeated measure and group as the non-repeated measure. When a significant group-by-time interaction was observed, an unpaired t-test was used for intergroup comparison at each time point, and the Bonferroni post hoc test was used for intragroup comparison during the interventional period. In a separate analysis, change in percentage from the baseline to the end of the study period was evaluated by using the unpaired t-test for intergroup comparison and the paired t-test for intragroup comparison. For the statistical analysis, Stat View for Windows (version 5, SAS Institute, Cary, NC) was used. All p values were two-tailed, and those less than 0.05 were considered statistically significant.
RESULTS

Participants' compliance
The participants were divided into two groups: Placebo group (n511; male, n55; female, n56; average age 65.861.4 y) and MFGM group (n511; male, n55; female, n56; average age 63.461.2 y). The age distribution of the participants in each group is shown in Table 1 . Participants' baseline characteristics were similar between the groups ( Table 2 ). The participants tolerated the intervention protocol well, and the overall compliance was .98% for each. No adverse side effects, due to the test tablets, or adverse events were reported throughout the study. All the participants completed the study after randomization. No significant difference in the daily physical activity as measured with the pedometer was found between the MFGM and Placebo groups (7,0136445 and 7,8456739 steps/d, respectively). The average daily intake of milk and dairy products during the study period was 143626 g (98618 kcal)/d in the MFGM group and 196650 g (131633 kcal)/d in the Placebo group. No significant intergroup difference was noted in dairy product intake.
Anthropometric values
No overall changes in body weight, whole body muscle mass, or body fat ratio were observed during the intervention period (Table 3) .
Physical function, muscle strength, and cross-sectional area
The chair stand time, which is an indicator of agility and muscular endurance, was significantly shortened after 10 wk compared with that at the baseline in both the MFGM and Placebo groups (Table 4) . However, the time was more substantially shortened in the MFGM group than in the Placebo group on average, although the change (%) was not statistically significant (Table 4) .
Knee extension strength markedly increased over the baseline after 10 wk in the MFGM group but not in the Placebo group (Table 4 ). In addition, the CSA of the quadriceps muscles significantly exceeded the baseline after 10 wk in the MFGM group but not in the Placebo group (Table 4) .
Surface electromyogram (EMG) parameters
RMS and MFCV were calculated from the EMG signal acquired from the vastus medialis of the male participants during isometric maximal voluntary contraction (Table 5) . A significant group-by-time interaction was found for MFCV during the interventional period. MFCV was significantly increased over baseline after 10 wk in the MFGM group but not in the Placebo group (Table  5 ). The change (%) of the MFCV from the baseline was significantly higher in the MFGM group than in the Placebo group. RMS, an indicator of motor unit activity, did not change significantly during the intervention period in either the MFGM or Placebo group, and there was no significant difference between the groups (Table 5) .
DISCUSSION
This study had two major findings. Daily ingestion of MFGM with semiweekly light exercise increased 1) muscle strength and mass, and 2) muscle fiber conduction velocity (MFCV) in healthy Japanese adults aged 60 and over. The results are consistent with the findings of our previous study, namely that dietary MFGM plus regular exercise improved agility, muscle mass, and MFCV in Japanese middle-aged adults (14) . This study was the first to demonstrate that daily MFGM intake, when combined with semiweekly light exercise, improves muscle function by increasing the conduction velocity of action potentials in the motor unit along the muscle fiber from Values are means6SE of 11 (Placebo group, male/female55/6) and 11 (MFGM group, male/female55/6) participants. 1 The value is the percentage change from the baseline to 10 wk. Two-way repeated-measures ANOVA for the group-by-time interaction (G3T) during the interventional period. Values are means6SE of 11 (Placebo group, male/female55/6) and 11 (MFGM group, male/female55/6) participants. 1 The value is the percentage change from the baseline to 10 wk. Two-way repeated-measures ANOVA for the group-by-time interaction (G3T) during the interventional period. * There was a significant difference from the baseline to 10 wk in results of the paired t-test (p,0.05).
the NMJ. Whereas 10 wk of semiweekly light exercise only (Placebo group) did not increase MFCV, when combined with daily supplementation of MFGM, MFCV was greatly increased. Since MFCV is an indicator of action potential conduction velocity in the motor unit, these findings suggest that neuromuscular function was improved by MFGM supplementation. This was also true for middleaged adults according to our previous study (14) .
Our recent animal study demonstrated that a major transcriptomic effect of dietary MFGM supplementation plus exercise was "nervous system development" in senescence-accelerated mice (12) . Docking protein-7 (Dok-7), a representative gene of NMJ formation (21) , was significantly elevated after dietary MFGM supplementation in the mice (12) . The NMJ plays a critical role in the conduction of action potentials from motor neuron to muscle fiber. Several studies have shown that human aging is associated with the gradual loss of motor neurons and morphological changes in the NMJ and its remodeling (22, 23) . The changes in NMJ morphology precede a functional impairment in the post-synaptic response of the NMJ, i.e., reduction in motor nerve conduction velocity and the amplitude of compound muscle action potential (24) . Aging-related NMJ abnormalities have been shown to cause muscular dysfunction (25) . Age-related fragmentation of the NMJ and accompanying denervation occurs more readily in fast muscle fibers than in slow muscle fibers, resulting in a progression toward slow muscle with age (26) . In addition, a seminal study by Arimura et al. has demonstrated that Dok-7-mediated enhancement of NMJ formation enlarged NMJs and substantially increased motor function in mice with functionally inefficient NMJs (27) . Overall, the increased MFCV and muscle strength following daily MFGM consumption found in this study, which aligns with the results of our previous studies on mice (12) and humans (14) , suggesting that daily MFGM supplementation combined with light exercise improved motor unit action potential conduction, thereby increasing muscle strength in adults aged 60 y and over.
However, semiweekly light exercise alone improved the chair stand performance of the participants in this study. This was inconsistent with our previous study in which a similar exercise program did not alter the physical performance of the middle-aged adults (14) . Contrary to our hypothesis, the beneficial effect of MFGM supplementation on physical performance in particular could not be distinguished from the effect of regular light exercise alone in the present study.
This study differed from our previous study in participants' baseline characteristics (14) . The participants in this study were senior to and had smaller baseline values (slower chair stand test time, weaker knee extension strength, smaller muscle CSA, and lower RMS and MFCV) than those in the previous study (14) . The differences in the baseline values between the studies could be explained by the fact that physical performance and muscle function tend to be considerably impaired over the age of 60 (15, 16) . The regular light exercise program alone used in this study may be beneficial to improve physical performance for older adults with reduced muscle and overall physical function, but daily MFGM supplementation did improve the chair stand performance more effectively than the semiweekly light exercise alone, though the difference was not statistically significant. The results imply that dietary MFGM supplementation has beneficial effects on physical performance, which can be distinguished from those resulting from exercise alone. Further studies with larger sample sizes are needed to clarify the beneficial effects of dietary MFGM supplementation on the physical performance of adults aged 60 y and over. Semiweekly light exercise alone did not improve muscle strength or muscle mass in the older adults in this study, which is in agreement with the results of our previous study (14) . In contrast to the muscle strength and mass, the RMS of the surface EMG, an indicator of motor unit activity, was significantly increased by exercise alone in our previous study, but was not changed by regular light exercise alone in the present study (14) . Cannon et al. showed that 10-wk regular resistance training increased EMG values even in older adult participants (28) , suggesting the improvement of motor unit recruitment. More intense exercise or resistance training might be required to stimulate motor unit activity in older adults.
Although improved physical performance and muscle function by way of intensive exercise prescriptions could potentially reduce fall risk in older adults (3, 4) , highintensity and long-term exercise training is not actually practical for older adults, so strategies to safely boost the efficacy of exercise are required for this population. Since the participants in this study had relatively active lifestyles with over 7,000 daily steps, the burden of the light exercise prescription in this study did not influence their daily activity levels. Seeing that dietary MFGM supplementation increased muscle mass and strength when combined with voluntary exercise in senescenceaccelerated mice (12) , these results together suggest that nutritional supplementation with MFGM combined with semiweekly light exercise is a practical therapeutic strategy for improving physical and muscular function in adults aged 60 y and over.
Although not detracting from the significance of the current findings, this study had several limitations. First, the study sample was small and limited to healthy older adults. In addition, although the age distributions of total and male participants were comparable for both groups, among female participants, only the Placebo group included two participants aged over 70 y. This could have led to potential differences in the response to the intervention, and, thus, some bias in the results. Further studies with larger numbers of participants are required, as well as consideration of older adults with sarcopenia and frailty. Second, the dose-dependency of the efficacy of MFGM and the optimal exercise intensity both remain to be clarified. Finally, the present study did not elucidate the active metabolites or underlying mechanisms for the beneficial effects of MFGM. Our previous study on mice suggested that sphingomyelin is one of the active components that accelerates neuromuscular development (13) . Further investigation employing biochemical and detailed EMG analysis is necessary to clarify the mechanisms.
In conclusion, this study provided evidence that daily nutritional supplementation with MFGM combined with semiweekly light exercise increased motor unit action potential conduction, thereby improving muscle strength and physical performance in healthy Japanese adults aged 60 and over. Improvement of physical and muscle function in older adults may decrease fall risk and increase quality of life. Our findings may indicate a potential usefulness of nutritional therapy using the milk-derived component in combination with light exercise for the extension of a healthy life span in older adults.
